Dianthus DNTH Investment Thesis Dianthus Therapeutics Inc posts 303 EPS miss with no revenue SNOA Sonoma Pharmaceuticals Inc Q1 2026 revenue growth drives 275 percent share gain despite narrow EPS miss Immunovant IMVT Innovation Pipeline Immunovant posts 163 EPS beat on narrower loss flyExclusive FLYX Stock Slowing Down 471 20260416 Is Independence IRT Stock Undervalued Now 019 20260415 PRTA Prothena Corporation plc Ordinary Shares rises 361 percent after Q4 2025 EPS outpaces analyst consensus estimates Herzfeld HERZ Stock Reversal Trade In Focus 20260418 Velo3D VELO Stock Downside Risk Review Q4 2025 Below Expectations SCOR comScore Inc posts 220 percent Q4 2025 EPS surprise stock gains 189 percent in regular trading CNVS Cineverse Corp posts 591 yearoveryear revenue growth beats EPS estimates but shares fall 207 today